These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 30523223

  • 1. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
    Chen J, Chen M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct 28; 43(10):1048-1053. PubMed ID: 30523223
    [Abstract] [Full Text] [Related]

  • 2. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K, Kato K, Matsuzaki J, Boku N, Abe S, Saito Y, Daiko H, Takizawa S, Aoki Y, Sakamoto H, Niida S, Takeshita F, Fukuda T, Ochiya T.
    JAMA Netw Open; 2019 May 03; 2(5):e194573. PubMed ID: 31125107
    [Abstract] [Full Text] [Related]

  • 3. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT, Guo CQ, Cui GH, Zhao S.
    World J Gastroenterol; 2019 Oct 07; 25(37):5604-5618. PubMed ID: 31602161
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
    Sun L, Dong S, Dong C, Sun K, Meng W, Lv P, Yin H, Ming L, He F.
    Cancer Biomark; 2016 Oct 07; 16(2):265-73. PubMed ID: 26756617
    [Abstract] [Full Text] [Related]

  • 6. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
    Li J, Li M, Gao F, Ge X.
    Cancer Biomark; 2017 Oct 07; 18(1):11-17. PubMed ID: 27802201
    [Abstract] [Full Text] [Related]

  • 7. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y, Xue Y, Dong S, Zhang P.
    J Int Med Res; 2017 Aug 07; 45(4):1310-1317. PubMed ID: 28587538
    [Abstract] [Full Text] [Related]

  • 8. Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Dong S, Yin H, Dong C, Sun K, Lv P, Meng W, Ming L, He F.
    Dis Markers; 2016 Aug 07; 2016():1857067. PubMed ID: 26989293
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
    Sun G, Ye H, Wang X, Li T, Jiang D, Qiu C, Dai L, Shi J, Wang K, Song C, Wang P, Zhang J.
    Cancer Med; 2020 Feb 07; 9(3):1173-1182. PubMed ID: 31856412
    [Abstract] [Full Text] [Related]

  • 10. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
    Chen CG, Cui L, Tang P, Yu ZT.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep 07; 16(9):838-41. PubMed ID: 24061989
    [Abstract] [Full Text] [Related]

  • 11. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
    Li SP, Su HX, Zhao D, Guan QL.
    Med Sci Monit; 2016 Jun 27; 22():2195-201. PubMed ID: 27345473
    [Abstract] [Full Text] [Related]

  • 12. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
    Huang Z, Zhang L, Zhu D, Shan X, Zhou X, Qi LW, Wu L, Zhu J, Cheng W, Zhang H, Chen Y, Zhu W, Wang T, Liu P.
    Cancer Med; 2017 Jan 27; 6(1):109-119. PubMed ID: 28035762
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and predictive significance of serum microRNA-7 in esophageal squamous cell carcinoma.
    Dong W, Li B, Wang J, Song Y, Zhang Z, Fu C, Zhang P.
    Oncol Rep; 2016 Mar 27; 35(3):1449-56. PubMed ID: 26708917
    [Abstract] [Full Text] [Related]

  • 14. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y.
    Tumour Biol; 2016 Apr 27; 37(4):4383-91. PubMed ID: 26499784
    [Abstract] [Full Text] [Related]

  • 15. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M, Hamasaki K, Wakata K, Tobinaga S, Sumida Y, Hidaka S, Yasutake T, Miyazaki T, Matsumoto K, Yamasaki T, Sawai T, Hamamoto R, Nanashima A, Nagayasu T.
    Anticancer Res; 2018 Mar 27; 38(3):1807-1813. PubMed ID: 29491120
    [Abstract] [Full Text] [Related]

  • 16. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.
    Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, Dai J, Hu Z, Zhou X, Chen L, Zhang Y, Li Y, Qiu H, Xing J, Liang Z, Ren B, Yang C, Zen K, Zhang CY.
    Clin Chem; 2010 Dec 27; 56(12):1871-9. PubMed ID: 20943850
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
    Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.
    PLoS One; 2014 Dec 27; 9(3):e92292. PubMed ID: 24651474
    [Abstract] [Full Text] [Related]

  • 18. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
    Niwa Y, Yamada S, Sonohara F, Kurimoto K, Hayashi M, Tashiro M, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.
    J Transl Med; 2019 Jan 03; 17(1):1. PubMed ID: 30602370
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
    Rong H, Chen B, Ma K, Wei X, Peng J, Zhu J.
    Cancer Biother Radiopharm; 2021 Apr 03; 36(3):273-279. PubMed ID: 32401035
    [Abstract] [Full Text] [Related]

  • 20. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X, Wen W, Zhu J, Huang Z, Zhang L, Zhang H, Qi LW, Shan X, Wang T, Cheng W, Zhu D, Yin Y, Chen Y, Zhu W, Shu Y, Liu P.
    Oncotarget; 2017 May 23; 8(21):34468-34480. PubMed ID: 28380431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.